EN22-0674-05_ Evaluation of the efficacy of the Investigational Product in the Restructuring of the Cutaneous Barrier through the kinetic phase, after the Tape Stripping procedure

Medcin Instituto da Pele Ltda0 个研究点开始时间: 2023年6月9日最近更新: 2023年6月26日

适应症

试验速览

暂无简介。

•Participants of both sexes; aged between 18 and 60 years; intact skin in the region of the forearms; agreement to follow the trial procedures and to attend the clinic on the day and times determined for applications and/or evaluations; understand, consent and sign the informed consent form

•Participants diagnosed with COVID-19 in the last 4 weeks or showing symptoms such as fever, dry cough, tiredness, body aches or other discomfort; pregnancy/lactation or intention to become pregnant during the study period; use of the following topical or systemic medications: immunosuppressants, antihistamines, non-steroidal anti-inflammatory drugs, and corticosteroids up to 30 days before selection or considering immunosuppressants, the interval should be 3 months before selection; history of atopy and history of allergies to cosmetic products; pathologies and/or active skin lesions (local and/or disseminated) in the evaluation area; skin marks in the experimental area that interfere with the evaluation of possible skin reactions (vascular malformations, scars, increased hairiness, large amounts of nevus, sunburn); pathologies that cause suppression of immunity, such as diabetes, HIV, etc.; decompensated endocrinopathies; participants with known congenital or acquired immunodeficiency; relevant medical history or current evidence of alcohol or other drug abuse; known history of or suspected intolerance to products in the same category; intense sun exposure up to 15 days before the evaluation; aesthetic or dermatological treatment in the evaluation area up to 04 weeks before selection; professionals directly involved in performing this study; other conditions considered by the evaluating physician as reasonable for disqualification from participation in the study

发起方